Paradigm Biopharmaceuticals Limited (PAR.AX)
AUD 0.37
(-2.67%)
AUD 0.37
(-2.67%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 65.1 Million AUD | 10.18% |
| 2023 | 59.09 Million AUD | 26.39% |
| 2022 | 46.75 Million AUD | 11.17% |
| 2021 | 42.05 Million AUD | 151.12% |
| 2020 | 16.74 Million AUD | 40.31% |
| 2019 | 11.93 Million AUD | 33.94% |
| 2018 | 8.91 Million AUD | 45.9% |
| 2017 | 6.1 Million AUD | 41.51% |
| 2016 | 4.31 Million AUD | 174.45% |
| 2015 | 1.57 Million AUD | 579.51% |
| 2014 | 231.43 Thousand AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 49.82 Million AUD | 0.0% |
| 2024 Q4 | 14.95 Million AUD | 0.0% |
| 2024 FY | 64.4 Million AUD | 8.99% |
| 2023 Q4 | 26.87 Million AUD | 0.0% |
| 2023 Q2 | 32.21 Million AUD | 0.0% |
| 2023 FY | 59.09 Million AUD | 26.39% |
| 2022 Q4 | 19.61 Million AUD | 0.0% |
| 2022 FY | 46.75 Million AUD | 11.17% |
| 2022 Q2 | 27.13 Million AUD | 0.0% |
| 2021 FY | 42.05 Million AUD | 151.12% |
| 2021 Q4 | 21.31 Million AUD | 0.0% |
| 2021 Q2 | 20.74 Million AUD | 0.0% |
| 2020 Q4 | 11.04 Million AUD | 0.0% |
| 2020 Q2 | 5.91 Million AUD | 0.0% |
| 2020 FY | 16.74 Million AUD | 40.31% |
| 2019 Q2 | 4.42 Million AUD | 0.0% |
| 2019 FY | 11.93 Million AUD | 33.94% |
| 2019 Q4 | 7.51 Million AUD | 0.0% |
| 2018 Q2 | 3.59 Million AUD | 0.0% |
| 2018 Q4 | 5.33 Million AUD | 0.0% |
| 2018 FY | 8.91 Million AUD | 45.9% |
| 2017 Q2 | 2.87 Million AUD | 0.0% |
| 2017 FY | 6.1 Million AUD | 41.51% |
| 2017 Q4 | 3.24 Million AUD | 0.0% |
| 2016 Q4 | 2.84 Million AUD | 0.0% |
| 2016 FY | 4.31 Million AUD | 174.45% |
| 2016 Q2 | 1.46 Million AUD | 0.0% |
| 2015 Q3 | - AUD | -100.0% |
| 2015 Q4 | 962.36 Thousand AUD | 0.0% |
| 2015 FY | 1.57 Million AUD | 579.51% |
| 2015 Q2 | 610.27 Thousand AUD | 0.0% |
| 2014 FY | 231.43 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 39.57 Million AUD | -64.508% |
| Anatara Lifesciences Ltd | 710.21 Thousand AUD | -9066.662% |
| Zelira Therapeutics Limited | 5.94 Million AUD | -994.445% |
| Biome Australia Limited | 7.91 Million AUD | -722.922% |
| Patrys Limited | 4.93 Million AUD | -1219.665% |
| Orthocell Limited | 15.36 Million AUD | -323.586% |
| Imugene Limited | 135.09 Million AUD | 51.808% |
| Noxopharm Limited | 7 Million AUD | -830.02% |
| PYC Therapeutics Limited | 60.91 Million AUD | -6.873% |
| Chimeric Therapeutics Limited | 19.76 Million AUD | -229.347% |
| Prescient Therapeutics Limited | 10.89 Million AUD | -497.344% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -7197.394% |
| Cynata Therapeutics Limited | 11.12 Million AUD | -485.273% |
| CSL Limited | 7.56 Billion AUD | 99.139% |
| Arovella Therapeutics Limited | 10.78 Million AUD | -503.63% |
| Bio-Gene Technology Limited | 2.76 Million AUD | -2257.945% |
| Clinuvel Pharmaceuticals Limited | 31.29 Million AUD | -108.017% |
| Starpharma Holdings Limited | 22.81 Million AUD | -185.34% |
| Nanollose Limited | 12.5 Thousand AUD | -520683.889% |
| Memphasys Limited | 3.67 Million AUD | -1669.887% |
| Invex Therapeutics Ltd | 3.34 Million AUD | -1845.77% |
| NeuroScientific Biopharmaceuticals Limited | 1.96 Million AUD | -3212.767% |
| Amplia Therapeutics Limited | 8.43 Million AUD | -671.756% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -10717.719% |
| Island Pharmaceuticals Limited | 4.12 Million AUD | -1478.123% |
| Race Oncology Limited | 14.77 Million AUD | -340.766% |
| Nyrada Inc. | 4.55 Million AUD | -1329.216% |
| Telix Pharmaceuticals Limited | 269.26 Million AUD | 75.822% |
| Dimerix Limited | 25.64 Million AUD | -153.88% |
| PharmAust Limited | 6.65 Million AUD | -877.968% |
| Immutep Limited | 42.87 Million AUD | -51.843% |
| Clarity Pharmaceuticals Ltd | 56.3 Million AUD | -15.621% |
| Alterity Therapeutics Limited | 23.4 Million AUD | -178.139% |
| BTC Health Limited | -1.03 Million AUD | 6366.388% |
| Acrux Limited | 8.55 Million AUD | -661.441% |
| Neuren Pharmaceuticals Limited | 32.69 Million AUD | -99.111% |
| Biotron Limited | 5.11 Million AUD | -1173.867% |
| Tissue Repair Ltd | 6.66 Million AUD | -876.527% |
| AdAlta Limited | 6.76 Million AUD | -861.712% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -21657.053% |
| Hexima Limited | 1 Million AUD | -6353.848% |
| AnteoTech Limited | 12.18 Million AUD | -434.202% |
| Recce Pharmaceuticals Ltd | 21.68 Million AUD | -200.23% |
| Avecho Biotechnology Limited | 4.54 Million AUD | -1332.289% |
| Actinogen Medical Limited | 22.77 Million AUD | -185.91% |
| Immuron Limited | 9.13 Million AUD | -612.451% |
| Argenica Therapeutics Limited | 8.26 Million AUD | -687.303% |